[(1-methyl-2-piperidinyl)methyl]amine diethanedioate, 95.0%, 1g

2,5-Dichloro-pyridine-3-sulfonic acid amide, 95.0%, 1g

1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-ol, 97.0%, 25g

4-BROMO-2-FLUORO-5-METHOXYBENZALDEHYDE, 95.0%, 5g

GC capillary column ROTI®Cap-1, 12 m, 0.20 mm, 0.20 µm, 1 Piece(s)

(3-(2-Ethoxy-2-oxoethoxy)phenyl)boronic acid, 95.0%, 5g

N-(2,3-dihydro-1H-inden-5-yl)acetamide, 95+%, 25g

4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine, 98%, 100mg

2-Bromo-5-chloromethylpyridine, 95.0%, 100mg

2-Bromo-N-isopropylacetamide, 95.0%, 5g

2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid, 98.0%, 1g

3-Azabicyclo[3.1.0]hexane hydrochloride, 95.0%, 1g

Phenylacetylene, 98.0%, 100g